Verathon Inc.
$672.8K 134 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Extremity Medical
Extremity Medical reported $672,925.44 across General Payments, Research, and Ownership to 438 physicians and teaching hospitals across 446 transactions.
- $672.9K Above-median payer
- All-tracks total
- 446 Above-median volume
- Transactions
- 438 Above-median reach
- Recipients
- −$105.0K
- General Payments vs PY2023
Extremity Medical reported $672,925.44 across all CMS Open Payments tracks (General + Research + Ownership) to 438 physicians and teaching hospitals in Program Year 2024 - ranking #699 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $657,862.49, averaging $1.5K per recipient.
How Extremity Medical's $672.9K all-tracks total breaks down
Extremity Medical's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
23/100
Total payments
F
16/100
Transaction volume
F
13/100
Physician reach
F
13/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer extremity-medical Extremity Medical
$672.9K · #699/1,925 · 0.0% industry · PY2024
- TOT $672.9K
- RANK #699
- SHARE 0.0%
- TXN 446
- RCP 438
- CAT 4
- GEN $657.9K
- ΔGEN −$105.0K
- TOP1 12.5%
- PY 2024
Volume peers
Nearest volume peer: Verathon Inc. ($672.8K)
Extremity Medical sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Extremity Medical's CMS-reported General Payments decreased by $105.0K (−13.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: EXTREMITY MEDICALPY2023: EXTREMITY MEDICALPY2024: Extremity Medical. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $762,889.28
- PY2024
- $657,862.49
What the Data Shows for Extremity Medical
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Extremity Medical, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
Of the 4 general-payment categories charted below, "Royalty or License" is the largest at $409.1K across 117 transactions, 62.2% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 4 types of general payments, Extremity Medical's largest category was "Royalty or License" at $409.1K - 62.2% of General Payments.
Extremity Medical reports 4 general-payment categories - the top three are Royalty or License (62.2%), Consulting Fee (28.1%), and Travel and Lodging (8.0%). The remaining 1 category make up 1.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Extremity Medical divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $409.1K | 117 | 62.2% |
| Consulting Fee | $184.5K | 58 | 28.1% |
| Travel and Lodging | $52.6K | 110 | 8.0% |
| Food and Beverage | $11.6K | 153 | 1.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $232,514.27 (35.3%) of $657,862.49 in this company's General Payments records across 149 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Extremity Medical
The five named recipients with the highest reported General Payments from this company
- 1
Christopher W DiGiovanni
$82,267.00 across 9 reported transactions
- 2
Vincent James Sammarco
$48,153.25 across 13 reported transactions
- 3
Jeffrey T Brodie
$41,132.63 across 7 reported transactions
- 4
Hospital for Special Surgery
$30,602.00 across 3 reported transactions
- 5
David Thordarson
$30,359.39 across 17 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Extremity Medical ranks #699 of 1,925 by total payments (top 36% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,353 of 1,838 by HHI (bottom 26% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Butterfly Network, Inc. : $100.3K total payments, HHI 434
- Acera Surgical, Inc. : $623.5K total payments, HHI 432
- Sirtex Medical Inc : $2.5M total payments, HHI 432
- Cycle Pharmaceuticals Inc : $34.4K total payments, HHI 430
- Eli Lilly and Company : $8.0M total payments, HHI 429
- ASD Specialty Healthcare, LLC : $5.3K total payments, HHI 428
- Extremity Medical (this company) : $657.9K total payments, HHI 428
- 3-D Matrix, Inc. : $51.0K total payments, HHI 427
- Fisher Scientific Company L.L.C. : $185.9K total payments, HHI 424
- Becton, Dickinson and Company : $7.8M total payments, HHI 423
- DentalEZ, Inc. : $20.1K total payments, HHI 422
- Evoke Pharma, Inc. : $292.8K total payments, HHI 422
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Extremity Medical's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Extremity Medical.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Extremity Medical.
Showing 6 of 1,924 companies with CMS-reported payment data.
Synapse Surgical LLC
$674.2K 0 recipients
Compare payment profiles
Teleflex Incorporated
$670.6K 117 recipients
Compare payment profiles
Aesculap Implant Systems, LLC
$670.4K 222 recipients
Compare payment profiles
Vascular Graft Solutions Inc
$668.1K 2 recipients
Compare payment profiles
Tempus AI, Inc
$683.5K 14,627 recipients
Compare payment profiles
Put this to use
Extremity Medical ranks #699 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just Extremity Medical. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.